1-20 of 72
Authors: Ken Garber
Journal Article
Oncologists Push Beyond New Lung Cancer Genomic Testing Guidelines Get access
JNCI: Journal of the National Cancer Institute, Volume 107, Issue 2, February 2015, djv023, https://doi.org/10.1093/jnci/djv023
Published: 12 February 2015
Journal Article
Promising Early Results for Immunotherapy–Antiangiogenesis Combination Get access
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 11, November 2014, dju392, https://doi.org/10.1093/jnci/dju392
Published: 13 November 2014
Journal Article
At Loose Ends: Telomere Theories of Aging and Cancer Begin To Converge Get access
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 11, 6 June 2012, Pages 803–806, https://doi.org/10.1093/jnci/djs271
Published: 06 June 2012
Journal Article
Evading Immunity: New Enzyme Implicated in Cancer Get access
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 5, 7 March 2012, Pages 349–352, https://doi.org/10.1093/jnci/djs152
Published: 07 March 2012
Journal Article
Genetic Discoveries Propagate New Epigenetic Drugs Get access
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 174–176, https://doi.org/10.1093/jnci/djs021
Published: 08 February 2012
Journal Article
Beyond Ipilimumab: New Approaches Target the Immunological Synapse Get access
JNCI: Journal of the National Cancer Institute, Volume 103, Issue 14, 20 July 2011, Pages 1079–1082, https://doi.org/10.1093/jnci/djr281
Published: 20 July 2011
Journal Article
Inducing Indigestion: Companies Embrace Autophagy Inhibitors Get access
JNCI: Journal of the National Cancer Institute, Volume 103, Issue 9, 4 May 2011, Pages 708–710, https://doi.org/10.1093/jnci/djr168
Published: 04 May 2011
Journal Article
Beyond Sequencing: New Diagnostic Tests Turn to Pathways Get access
JNCI: Journal of the National Cancer Institute, Volume 103, Issue 4, 16 February 2011, Pages 290–292, https://doi.org/10.1093/jnci/djr042
Published: 16 February 2011
Journal Article
Ready or Not: Personal Tumor Profiling Tests Take Off Get access
JNCI: Journal of the National Cancer Institute, Volume 103, Issue 2, 19 January 2011, Pages 84–86, https://doi.org/10.1093/jnci/djq556
Published: 19 January 2011
Journal Article
Of Ephs and Ephrins: Companies Target Guidance Molecules in Cancer Get access
JNCI: Journal of the National Cancer Institute, Volume 102, Issue 22, 17 November 2010, Pages 1692–1694, https://doi.org/10.1093/jnci/djq479
Published: 17 November 2010
Journal Article
A Tale of Two Cells: Discovering the Origin of Prostate Cancer Get access
JNCI: Journal of the National Cancer Institute, Volume 102, Issue 20, 20 October 2010, Pages 1528–1535, https://doi.org/10.1093/jnci/djq425
Published: 20 October 2010
Journal Article
Oncometabolite? IDH1 Discoveries Raise Possibility of New Metabolism Targets in Brain Cancers and Leukemia Get access
JNCI: Journal of the National Cancer Institute, Volume 102, Issue 13, 7 July 2010, Pages 926–928, https://doi.org/10.1093/jnci/djq262
Published: 07 July 2010
Journal Article
ALK, Lung Cancer, and Personalized Therapy: Portent of the Future? Get access
JNCI: Journal of the National Cancer Institute, Volume 102, Issue 10, 19 May 2010, Pages 672–675, https://doi.org/10.1093/jnci/djq184
Published: 19 May 2010
Journal Article
Stromal Depletion Goes on Trial in Pancreatic Cancer Get access
JNCI: Journal of the National Cancer Institute, Volume 102, Issue 7, 2010, Pages 448–450, https://doi.org/10.1093/jnci/djq113
Published: 07 April 2010
Journal Article
Parkinson's Disease and Cancer: The Unexplored Connection Get access
JNCI: Journal of the National Cancer Institute, Volume 102, Issue 6, 17 March 2010, Pages 371–374, https://doi.org/10.1093/jnci/djq081
Published: 17 March 2010
Journal Article
Companies Waver in Efforts To Target Transforming Growth Factor β in Cancer Get access
JNCI: Journal of the National Cancer Institute, Volume 101, Issue 24, 16 December 2009, Pages 1664–1667, https://doi.org/10.1093/jnci/djp462
Published: 16 December 2009
Journal Article
First Results for Agents Targeting Cancer-Related Inflammation Get access
JNCI: Journal of the National Cancer Institute, Volume 101, Issue 16, 19 August 2009, Pages 1110–1112, https://doi.org/10.1093/jnci/djp266
Published: 19 August 2009
Journal Article
JAK2 Inhibitors: Not the Next Imatinib But Researchers See Other Possibilities Get access
JNCI: Journal of the National Cancer Institute, Volume 101, Issue 14, 15 July 2009, Pages 980–982, https://doi.org/10.1093/jnci/djp216
Published: 15 July 2009
Journal Article
Drugging the Wnt Pathway: Problems And Progress Get access
JNCI: Journal of the National Cancer Institute, Volume 101, Issue 8, 15 April 2009, Pages 548–550, https://doi.org/10.1093/jnci/djp084
Published: 15 April 2009
Journal Article
Targeting mTOR: Something Old, Something New Get access
JNCI: Journal of the National Cancer Institute, Volume 101, Issue 5, 4 March 2009, Pages 288–290, https://doi.org/10.1093/jnci/djp034
Published: 04 March 2009
